Previous 10 | Next 10 |
home / stock / ehvvf / ehvvf news
MIAMI, March 21, 2022 (GLOBE NEWSWIRE) -- Mycotopia Therapies Inc. (OTC Pink: TPIA) (the “Company”), a biopharma company focused on research, technology, and the development of medical psychedelics, announced today plans to enter the $13 billion medicinal mushroom market w...
Agreement with Heally adds doctors, licensed psychotherapists and registered nurses to the KetaDASH platform With the opening of KetaDASH, Ehave builds momentum for the psychedelic renaissance in the mental health field Both the KetaDASH patient and nurse connect to a psychother...
Ehave has licensed AI technology from Vastmindz for MetaHealthU. in 2022, Ehave plans to monetize the AI technology it licensed from Vastmindz to expand the Ehave Dashboard in the MetaHealthU offering to identify an individual's physiological condition, such as Heart Rate, Heart Rate ...
Ehave, Inc. (OTC Pink: EHVVF) reported that its wholly-owned subsidiary, KetaDASH has started clinical operations that are offering in-home ketamine therapy to patients suffering from treatment-resistant mental health issues. Ehave said that the treatment will be offered i...
KetaDASH will provide ketamine therapy for the treatment of mental health disorders KetaDASH is a managed service organization focused on the psychedelic sector with the mission of helping physicians streamline their practice operations, create new revenue opportunities, and achieve b...
MIAMI, Feb. 09, 2022 (GLOBE NEWSWIRE) -- Ehave, Inc. (OTC Pink: EHVVF) (the “Company”), a leading healthcare services and technology company, reaffirms its commitment to shareholders to launch its KetaDASH brand by completing the purchase of 100% of Rejuv IV . ...
MIAMI, Jan. 31, 2022 (GLOBE NEWSWIRE) -- Ehave, Inc., (OTC Pink: EHVVF) (the “Company”), a provider of digital therapeutics for the psychedelic and mental health sectors, today issued a letter to shareholders from its Chief Executive Officer, Ben Kaplan. Dear Fellow Sh...
Mycotopia and Ei.Ventures announced the signing of an LOI to explore a merger and the formation of PSLY.COM, a $360 Million transaction, and will apply to list shares on NASDAQ; Ehave plans to spin out 30% MIAMI, Dec. 08, 2021 (GLOBE NEWSWIRE) -- Ehave, Inc. , (OTC Pink: EHV...
Wonderland: Miami is hosted by Microdose and engages some of the greatest minds in the Psychedelic Sector, by fostering creative and professional growth Miami, Florida--(Newsfile Corp. - November 5, 2021) - Ehave, Inc., (OTC Pink: EHVVF) (the "Company"), a provider of digital therapeuti...
MIAMI, Oct. 20, 2021 (GLOBE NEWSWIRE) -- Ehave, Inc., (OTC Pink: EHVVF) (the “Company”), a provider of digital therapeutics for the psychedelic and mental health sectors, announced today its wholly owned KetaDASH will be one of the sponsors of the 2021 Psychedelic Investor Gui...
News, Short Squeeze, Breakout and More Instantly...
MIAMI, Feb. 02, 2023 (GLOBE NEWSWIRE) -- Ehave, Inc. (OTC Pink: EHVVF) (the "Company"), a Healthcare Analytics provider with interests in the psychedelic and mental health sectors, is pleased to announce it has completed the first phase of its series of studies with the University of Melbourne to...
MIAMI, Dec. 15, 2022 (GLOBE NEWSWIRE) -- Ehave, Inc., (OTC Pink: EHVVF) (the “Company”), a Healthcare Analytics provider with interests in the psychedelic and mental health sectors, announced today that it received confirmation from the U.S. Food and Drug Administration ("FDA") that...
MIAMI, Dec. 07, 2022 (GLOBE NEWSWIRE) -- Ehave, Inc., (OTC Pink: EHVVF) (the “Company”) , a Healthcare Analytics provider with interests in the psychedelic and mental health sectors, today issued a letter to shareholders from its Chief Executive Officer, Ben Kaplan. Dear Fel...